SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 73 filers reported holding SAVARA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $620,472 | +18.3% | 164,146 | 0.0% | 0.00% | – |
Q2 2023 | $524,446 | +58.7% | 164,146 | -3.2% | 0.00% | – |
Q1 2023 | $330,542 | +260169.3% | 169,509 | +108.2% | 0.00% | – |
Q4 2022 | $127 | -99.9% | 81,408 | 0.0% | 0.00% | – |
Q3 2022 | $126,000 | -13.7% | 81,408 | -15.4% | 0.00% | – |
Q2 2022 | $146,000 | +9.8% | 96,194 | -5.3% | 0.00% | – |
Q1 2022 | $133,000 | 0.0% | 101,550 | -5.3% | 0.00% | – |
Q4 2021 | $133,000 | -10.1% | 107,285 | 0.0% | 0.00% | – |
Q3 2021 | $148,000 | -18.7% | 107,285 | 0.0% | 0.00% | – |
Q2 2021 | $182,000 | -26.6% | 107,285 | -10.1% | 0.00% | – |
Q1 2021 | $248,000 | +95.3% | 119,383 | +8.1% | 0.00% | – |
Q4 2020 | $127,000 | -12.4% | 110,407 | -17.1% | 0.00% | – |
Q3 2020 | $145,000 | -58.9% | 133,125 | -6.0% | 0.00% | – |
Q2 2020 | $353,000 | +122.0% | 141,618 | +89.2% | 0.00% | – |
Q1 2020 | $159,000 | -57.7% | 74,849 | -47.2% | 0.00% | – |
Q3 2019 | $376,000 | +46.9% | 141,788 | +31.1% | 0.00% | – |
Q2 2019 | $256,000 | -46.4% | 108,149 | +66.8% | 0.00% | – |
Q1 2019 | $478,000 | -2.6% | 64,828 | 0.0% | 0.00% | – |
Q4 2018 | $491,000 | -32.1% | 64,828 | 0.0% | 0.00% | – |
Q3 2018 | $723,000 | -1.5% | 64,828 | 0.0% | 0.00% | – |
Q2 2018 | $734,000 | +543.9% | 64,828 | +424.5% | 0.00% | – |
Q1 2018 | $114,000 | -37.7% | 12,359 | 0.0% | 0.00% | – |
Q4 2017 | $183,000 | – | 12,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |